{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T07:53:42Z","timestamp":1789372422013,"version":"build-2803163510"},"reference-count":55,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2008,4,1]],"date-time":"2008-04-01T00:00:00Z","timestamp":1207008000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["L'Enc\u00e9phale"],"published-print":{"date-parts":[[2008,4]]},"DOI":"10.1016\/j.encep.2007.07.003","type":"journal-article","created":{"date-parts":[[2008,4,23]],"date-time":"2008-04-23T08:27:03Z","timestamp":1208939223000},"page":"194-204","source":"Crossref","is-referenced-by-count":3,"title":["Les antipsychotiques atypiques dans le premier \u00e9pisode psychotique\u00a0: revue de la litt\u00e9rature"],"prefix":"10.1016","volume":"34","author":[{"given":"J.-Y.","family":"Rotg\u00e9","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Aouizerate","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Tignol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.encep.2007.07.003_bib1","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/S0920-9964(97)82553-4","article-title":"Efficacy of risperidone in first-episode schizophrenia","volume":"24","author":"Ahmed","year":"1997","journal-title":"Schizophr Res"},{"key":"10.1016\/j.encep.2007.07.003_bib2","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1017\/S1461145703003742","article-title":"Minimum effective doses of haloperidol for the treatment of first psychotic episode: a comparative study with risperidone and olanzapine","volume":"6","author":"Apiquian","year":"2003","journal-title":"Int J Neuropsychopharmacol"},{"key":"10.1016\/j.encep.2007.07.003_bib3","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/S0278-5846(03)00035-6","article-title":"Safety and effectiveness of olanzapine versus conventional antipsychotics in the acute treatment of first-episode schizophrenic inpatients","volume":"27","author":"Bobes","year":"2003","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"issue":"19","key":"10.1016\/j.encep.2007.07.003_bib4","first-page":"9","article-title":"Pharmacologic treatment of first-episode schizophrenia: early intervention is key to outcome","volume":"59","author":"Dequardo","year":"1998","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.encep.2007.07.003_bib5","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/0924-977X(95)90596-6","article-title":"Risperidone in the treatment of first-episode patients with schizophreniform disorder: a double-blind multicenter study","volume":"5","author":"Emsley","year":"1995","journal-title":"Eur Neuropsychopharmacol"},{"key":"10.1016\/j.encep.2007.07.003_bib6","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1093\/oxfordjournals.schbul.a033413","article-title":"Risperidone in the treatment of first-episode psychotic patients: a double-blind multicenter study","volume":"25","author":"Emsley","year":"1999","journal-title":"Schizophr Bull"},{"issue":"10","key":"10.1016\/j.encep.2007.07.003_bib7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1017\/S1092852900025748","article-title":"Are we treating schizophrenia effectively? Understanding the primary outcomes of the CATIE study","volume":"9","author":"Glazer","year":"2006","journal-title":"CNS Spectr"},{"issue":"43","key":"10.1016\/j.encep.2007.07.003_bib8","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1192\/bjp.181.43.s45","article-title":"Improvement in cognitive functioning in patients with first-episode psychosis during treatment with quetiapine: an interim analysis","volume":"181","author":"Good","year":"2002","journal-title":"Br J Psychiatry"},{"key":"10.1016\/j.encep.2007.07.003_bib9","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1176\/appi.ajp.162.1.118","article-title":"Effect of olanzapine on body composition and energy expenditure in adults with first-episode psychosis","volume":"162","author":"Graham","year":"2005","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.encep.2007.07.003_bib10","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.schres.2003.08.001","article-title":"First episode schizophrenia-related psychosis and substance use disorders: acute response to olanzapine and haloperidol","volume":"66","author":"Green","year":"2004","journal-title":"Schizophr Res"},{"key":"10.1016\/j.encep.2007.07.003_bib11","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1017\/S0033291705006756","article-title":"Longitudinal studies of antisaccades in antipsychotic-naive first-episode schizophrenia","volume":"36","author":"Harris","year":"2006","journal-title":"Psychol Med"},{"key":"10.1016\/j.encep.2007.07.003_bib12","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.1176\/appi.ajp.162.10.1888","article-title":"Treatment of cognitive impairment in early psychosis: a comparison of risperidone and haloperidol in a large long-term trial","volume":"162","author":"Harvey","year":"2005","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.encep.2007.07.003_bib13","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1176\/appi.ajp.163.2.185","article-title":"Why olanzapine beats risperidone, risperidone beats quetiapine, and quetiapine beats olanzapine: an exploratory analysis of head-to-head comparison studies of second-generation antipsychotics","volume":"163","author":"Heres","year":"2006","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.encep.2007.07.003_bib14","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1097\/01.jcp.0000115663.45074.8a","article-title":"A trial of low doses of risperidone in the treatment of patients with first-episode schizophrenia, schizophreniform disorder, or schizoaffective disorder","volume":"24","author":"Huq","year":"2004","journal-title":"J Clin Psychopharmacol"},{"issue":"14","key":"10.1016\/j.encep.2007.07.003_bib15","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1177\/070674370505001403","article-title":"Long-term outcome of patients with schizophrenia: a review","volume":"50","author":"Jobe","year":"2005","journal-title":"Can J Psychiatry"},{"key":"10.1016\/j.encep.2007.07.003_bib16","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1093\/schbul\/13.2.261","article-title":"The positive and negative syndrome scale (PANSS) for schizophrenia","volume":"13","author":"Kay","year":"1987","journal-title":"Schizophr Bull"},{"key":"10.1016\/j.encep.2007.07.003_bib17","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1176\/appi.ajp.161.6.985","article-title":"Comparative effect of atypical and conventional antipsychotic drugs on neurocognition in first-episode psychosis: a randomized, double-blind trial of olanzapine versus low doses of haloperidol","volume":"161","author":"Keefe","year":"2004","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.encep.2007.07.003_bib18","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.biopsych.2005.06.022","article-title":"Long-term neurocognitive effects of olanzapine or low-dose haloperidol in first-episode psychosis","volume":"15","author":"Keefe","year":"2006","journal-title":"Biol Psychiatry"},{"issue":"33","key":"10.1016\/j.encep.2007.07.003_bib19","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1192\/S0007125000297675","article-title":"Research and treatment strategies in first-episode psychoses","volume":"172","author":"Keshavan","year":"1998","journal-title":"Br J Psychiatry"},{"key":"10.1016\/j.encep.2007.07.003_bib20","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1176\/appi.ajp.157.7.1178-a","article-title":"Optimal risperidone dose in drug-naive, first-episode schizophrenia","volume":"157","author":"Kontaxakis","year":"2000","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.encep.2007.07.003_bib21","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/0006-3223(95)00500-5","article-title":"Symptoms in neuroleptic-naive, first-episode schizophrenia: response to risperidone","volume":"39","author":"Kopala","year":"1996","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.encep.2007.07.003_bib22","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1097\/00004714-199708000-00011","article-title":"Extrapyramidal signs and clinical symptoms in first-episode schizophrenia: response to low-dose risperidone","volume":"17","author":"Kopala","year":"1997","journal-title":"J Clin Psychopharm"},{"key":"10.1016\/j.encep.2007.07.003_bib23","first-page":"s19","article-title":"Risperidone in first-episode schizophrenia: improvement in symptoms and pre-existing extrapyramidal signs","volume":"2","author":"Kopala","year":"1998","journal-title":"Int J Psychiatry Clin Pract"},{"key":"10.1016\/j.encep.2007.07.003_bib24","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.schres.2005.09.009","article-title":"Treatment of a first episode of psychotic illness with quetiapine: an analysis of 2 year outcomes","volume":"81","author":"Kopala","year":"2006","journal-title":"Schizophr Res"},{"key":"10.1016\/j.encep.2007.07.003_bib25","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1097\/00004850-200309000-00001","article-title":"Objective and subjective efficacy as well as tolerability of olanzapine in the acute treatment of 120 patients with schizophrenia spectrum disorders","volume":"18","author":"Lambert","year":"2003","journal-title":"Int Clin Psychopharmacol"},{"key":"10.1016\/j.encep.2007.07.003_bib26","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1517\/14656566.4.5.717","article-title":"Pharmacotherapy of first-episode psychosis","volume":"4","author":"Lambert","year":"2003","journal-title":"Expert Opin Pharmacother"},{"key":"10.1016\/j.encep.2007.07.003_bib27","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1055\/s-2005-873155","article-title":"Comparison of olanzapine and risperidone in 367 first-episode patients with non-affective or affective psychosis: results of an open retrospective medical record study","volume":"38","author":"Lambert","year":"2005","journal-title":"Pharmacopsychiatry"},{"key":"10.1016\/j.encep.2007.07.003_bib28","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1111\/j.1600-0447.2005.00554.x","article-title":"The impact of substance use disorders on clinical outcome in 643 patients with first-episode psychosis","volume":"112","author":"Lambert","year":"2005","journal-title":"Acta Psychiatr Scand"},{"key":"10.1016\/j.encep.2007.07.003_bib29","doi-asserted-by":"crossref","first-page":"994","DOI":"10.4088\/JCP.v62n1214c","article-title":"A pilot double-blind, dose-comparison study of risperidone in drug-naive, first-episode schizophrenia","volume":"62","author":"Lane","year":"2001","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.encep.2007.07.003_bib30","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S0140-6736(97)08468-7","article-title":"Summing up evidence: one answer is not always enough","volume":"351","author":"Lau","year":"1998","journal-title":"Lancet"},{"issue":"Feb suppl.","key":"10.1016\/j.encep.2007.07.003_bib31","article-title":"American psychiatric association practice guideline for the treatment of patients with schizophrenia","volume":"161","author":"Lehman","year":"2004","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.encep.2007.07.003_bib32","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1176\/appi.ajp.160.8.1396","article-title":"Comparative efficacy and safety of atypical and conventional antipsychotic drugs in first-episode psychosis: a randomized, double-blind trial of olanzapine versus haloperidol","volume":"160","author":"Lieberman","year":"2003","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.encep.2007.07.003_bib33","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1038\/sj.npp.1300157","article-title":"Atypical and conventional antipsychotic drugs in treatment-naive first-episode schizophrenia: a 52-week randomized trial of clozapine vs chlorpromazine","volume":"28","author":"Lieberman","year":"2003","journal-title":"Neuropsychopharmacol"},{"key":"10.1016\/j.encep.2007.07.003_bib34","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.psychres.2004.07.008","article-title":"A comparison of two novel antipsychotics in first episode non-affective psychosis: one-year outcome on symptoms, motor side effects and cognition","volume":"129","author":"Malla","year":"2004","journal-title":"Psychiatry Res"},{"key":"10.1016\/j.encep.2007.07.003_bib35","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1001\/archpsyc.1991.01810320063009","article-title":"Optimal dose of neuroleptic in acute schizophrenia. A controlled study of the neuroleptic threshold and higher haloperidol dose","volume":"48","author":"McEvoy","year":"1991","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.encep.2007.07.003_bib36","doi-asserted-by":"crossref","first-page":"794","DOI":"10.4088\/JCP.v60n1118","article-title":"Recommended haloperidol and risperidone doses in first-episode psychosis [letter with reply]","volume":"60","author":"McGorry","year":"1999","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.encep.2007.07.003_bib37","doi-asserted-by":"crossref","first-page":"885","DOI":"10.4088\/JCP.v63n1006","article-title":"Risperidone, 2mg\/day vs. 4mg\/day, in first-episode, acutely psychotic patients: treatment efficacy and effects on fine motor functioning","volume":"63","author":"Merlo","year":"2002","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.encep.2007.07.003_bib38","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/S0920-9964(97)82559-5","article-title":"Risperidone versus haloperidol in a prospective longitudinal follow-up of recent-onset schizophrenia","volume":"24","author":"Miller","year":"1997","journal-title":"Schizophr Res"},{"key":"10.1016\/j.encep.2007.07.003_bib39","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/S0278-5846(03)00077-0","article-title":"Safety, effectiveness, and quality of life of olanzapine in first-episode schizophrenia: a naturalistic study","volume":"27","author":"Montes","year":"2003","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"10.1016\/j.encep.2007.07.003_bib40","doi-asserted-by":"crossref","first-page":"s445","DOI":"10.1016\/j.euroneuro.2004.08.003","article-title":"Clinical effectiveness in first-episode patients","volume":"14","author":"Ohlsen","year":"2004","journal-title":"Eur Neuropsychopharmacol"},{"key":"10.1016\/j.encep.2007.07.003_bib41","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1192\/bjp.185.1.18","article-title":"Predictors of antipsychotic treatment response in patients with first-episode schizophrenia, schizoaffective and schizophreniform disorders","volume":"185","author":"Perkins","year":"2004","journal-title":"Br J Psychiatry"},{"key":"10.1016\/j.encep.2007.07.003_bib42","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1176\/appi.ajp.162.10.1785","article-title":"Relationship between duration of untreated psychosis and outcome in first-episode schizophrenia: a critical review and meta-analysis","volume":"162","author":"Perkins","year":"2005","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.encep.2007.07.003_bib43","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1001\/archpsyc.57.3.249","article-title":"Neuropsychological change in early phase schizophrenia during 12 months of treatment with olanzapine, risperidone, or haloperidol","volume":"57","author":"Purdon","year":"2000","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.encep.2007.07.003_bib44","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/S0920-9964(97)82561-3","article-title":"Pilot study of atypical antipsychotic agents in first episode schizophrenia","volume":"24","author":"Robinson","year":"1997","journal-title":"Schizophr Res"},{"key":"10.1016\/j.encep.2007.07.003_bib45","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1176\/ajp.156.1.79","article-title":"Olanzapine versus haloperidol treatment in first-episode psychosis","volume":"156","author":"Sanger","year":"1999","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.encep.2007.07.003_bib46","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1176\/appi.ajp.162.5.947","article-title":"Risperidone and haloperidol in first-episode psychosis: a long-term randomized trial","volume":"162","author":"Schooler","year":"2005","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.encep.2007.07.003_bib47","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.schres.2005.07.024","article-title":"Weight gain and lipid metabolic abnormalities induced by olanzapine in first-episode, drug-na\u00efve patients with psychotic disorders","volume":"80","author":"Sengupta","year":"2005","journal-title":"Schizophr Res"},{"key":"10.1016\/j.encep.2007.07.003_bib48","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1016\/S0013-7006(05)82427-3","article-title":"Analysis of differential clinical profiles of different antipsychotic molecules in the first psychotic episode: a retrospective study","volume":"31","author":"Spanarello","year":"2005","journal-title":"Enc\u00e9phale"},{"key":"10.1016\/j.encep.2007.07.003_bib49","doi-asserted-by":"crossref","first-page":"992","DOI":"10.4088\/JCP.v63n1106","article-title":"Quetiapine: an effective antipsychotic in first-episode schizophrenia despite only transiently high dopamine-2 receptor blockade","volume":"63","author":"Tauscher-Wisniewski","year":"2002","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.encep.2007.07.003_bib50","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/S0920-9964(97)82552-2","article-title":"Olanzapine versus haloperidol in the treatment of first episode psychosis","volume":"24","author":"Tollefson","year":"1997","journal-title":"Schizophr Res"},{"key":"10.1016\/j.encep.2007.07.003_bib51","doi-asserted-by":"crossref","first-page":"282","DOI":"10.4088\/JCP.v62n0411","article-title":"Optimal dosing with risperidone: updated recommendations","volume":"62","author":"Williams","year":"2001","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.encep.2007.07.003_bib52","first-page":"112","article-title":"Anchoring the BPRS: an aid to improve reliability","volume":"24","author":"Woerner","year":"1988","journal-title":"Psychopharmacol Bull"},{"key":"10.1016\/j.encep.2007.07.003_bib53","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.1176\/appi.ajp.160.8.1514","article-title":"Clozapine as a first treatment for schizophrenia","volume":"160","author":"Woerner","year":"2003","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.encep.2007.07.003_bib54","first-page":"170","article-title":"Risperidone in the treatment of first episode psychosis","volume":"42","author":"Yap","year":"2001","journal-title":"Singapore Med J"},{"key":"10.1016\/j.encep.2007.07.003_bib55","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1192\/bjp.187.6.537","article-title":"Course and predictors of weight gain in people with first-episode psychosis treated with olanzapine or haloperidol","volume":"187","author":"Zipursky","year":"2005","journal-title":"Br J Psychiatry"}],"container-title":["L'Enc\u00e9phale"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0013700607000450?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0013700607000450?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,5,10]],"date-time":"2019-05-10T13:10:18Z","timestamp":1557493818000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0013700607000450"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,4]]},"references-count":55,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2008,4]]}},"alternative-id":["S0013700607000450"],"URL":"https:\/\/doi.org\/10.1016\/j.encep.2007.07.003","relation":{},"ISSN":["0013-7006"],"issn-type":[{"value":"0013-7006","type":"print"}],"subject":[],"published":{"date-parts":[[2008,4]]}}}